Benzinga's Top Pre-Market Gainers

Benzinga's Top Pre-Market Gainers

By: Latest Articles from Benzinga.com

Posted on December 28, 2012 at 08:14 AM EST

Aeterna Zentaris (NASDAQ: AEZS ) added 4.15% to $2.26 in the pre-market session. Aeterna Zentaris granted Special Protocol Assessment by the U.S. Food and Drug Administration for Phase 3 registration trial in endometrial cancer with AEZS-108. Arena Pharmaceuticals (NASDAQ: ARNA ) moved up 1.71% to $8.94 in the pre-market

Related Stocks:

AETERNA ZENTARIS Arena Pharmaceuticals, Inc. LSI Marvell Technology Group Ltd NewStar Financial, Inc.

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates